Research programme: anticancer small molecule therapeutics - MOMA Therapeutics/Roche
Latest Information Update: 28 Mar 2025
At a glance
- Originator Roche
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer